WT1 vaccines against breast cancer and other types of cancer such as lung, leukemia and pancreatic cancer are currently under phase I or phase II clinical trials highlighting its value in precision medicine (Zhang et al., 2020). The gene discussed is WT1; the disease is breast carcinoma.